Cerulean Pharma Inc (NASDAQ:CERU) was the target of a large increase in short interest in the month of April. As of April 28th, there was short interest totalling 2,728,058 shares, an increase of 14.9% from the April 13th total of 2,374,061 shares. Based on an average daily trading volume, of 630,298 shares, the days-to-cover ratio is currently 4.3 days.

Shares of Cerulean Pharma (NASDAQ:CERU) opened at 0.4313 on Tuesday. The company’s 50 day moving average price is $0.62 and its 200 day moving average price is $0.92. Cerulean Pharma has a one year low of $0.33 and a one year high of $3.58. The stock’s market capitalization is $12.52 million.

A hedge fund recently raised its stake in Cerulean Pharma stock. KCG Holdings Inc. raised its stake in Cerulean Pharma Inc (NASDAQ:CERU) by 3,217.8% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 780,833 shares of the biotechnology company’s stock after buying an additional 757,298 shares during the period. KCG Holdings Inc. owned about 2.69% of Cerulean Pharma worth $634,000 at the end of the most recent quarter. Institutional investors and hedge funds own 22.90% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Cerulean Pharma Inc (CERU) Sees Significant Increase in Short Interest” was first reported by American Banking News and is owned by of American Banking News. If you are accessing this report on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/05/16/cerulean-pharma-inc-ceru-sees-significant-increase-in-short-interest.html.

About Cerulean Pharma

Cerulean Pharma Inc is a clinical-stage, oncology-focused company. The Company applies its Dynamic Tumor Targeting platform to develop differentiated therapies. Its platform utilizes nanoparticle-drug conjugates (NDCs), which consist of polymers that are covalently linked to anti-cancer therapeutics or payloads.

5 Day Chart for NASDAQ:CERU

Receive News & Ratings for Cerulean Pharma Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerulean Pharma Inc and related companies with MarketBeat.com's FREE daily email newsletter.